OnKure Therapeutics Announces Registration Of Up To $100M At-The-Market Offering Of Class A Common Stock Through Leerink Partners

Benzinga Newsdesk www.benzinga.com Neutral 92.5%

Neg 0% Neu 92.5% Pos 0%

https://www.sec.gov/Archives/edgar/data/1637715/000119312526332839/okur_424b5-20260804.htm

Comments

No comments yet. Be the first!